Found 8 results
Filters: Author is A.G. Tomatir  [Clear All Filters]
I. Acikbas, Tomatir, A. G., Akdag, B., and Köksal, A., Retrospective analysis of live birth prevalence of children with Down syndrome in Denizli, Turkey, vol. 11, pp. 4640-4645, 2012.
Adams MM, Erickson JD, Layde PM and Oakley GP (1981). Down's syndrome. Recent trends in the United States. JAMA 246: 758-7b60.   Balkan M, Akbas H, Isi H, Oral D, et al. (2010). Cytogenetic analysis of 4216 patients referred for suspected chromosomal abnormalities in Southeast Turkey. Genet. Mol. Res. 9: 1094-1103. PMid:20568054   Boduroglu K, Alanay Y, Koldan B and Tuncbilek E (2004). Methylenetetrahydrofolate reductase enzyme polymorphisms as maternal risk for Down syndrome among Turkish women. Am. J. Med. Genet. A 127A: 5-10. PMid:15103709   Carothers AD, Hecht CA and Hook EB (1999). International variation in reported livebirth prevalence rates of Down syndrome, adjusted for maternal age. J. Med. Genet. 36: 386-393. PMid:10353785 PMCid:1734363   Cetiner S, Demirhan O, Inal TC, Tastemir D, et al. (2010). Analysis of peripheral blood T-cell subsets, natural killer cells and serum levels of cytokines in children with Down syndrome. Int. J. Immunogenet. 37: 233-237. PMid:20477881   de Graaf G, Haveman M, Hochstenbach R, Engelen J, et al. (2011). Changes in yearly birth prevalence rates of children with Down syndrome in the period 1986-2007 in The Netherlands. J. Intellect. Disabil. Res. 55: 462-473. PMid:21375641   Dolk H, Loane M, Garne E, De Walle H, et al. (2005). Trends and geographic inequalities in the prevalence of Down syndrome in Europe, 1980-1999. Rev. Epidemiol. Sante Publique 53: 2S87-2S95.   Duarte AC, Cunha E, Roth JM, Ferreira FL, et al. (2004). Cytogenetics of genetic counseling patients in Pelotas, Rio Grande do Sul, Brazil. Genet. Mol. Res. 3: 303-308. PMid:15614723   EUROCAT - European Surveillance of Congenital Anomalies (2011). Available at []. Accessed September 5, 2011.   General Directorate of Civil Registration and Nationality Web Services (2011). Available at [,Statistikler_Main.html]. Accessed September 6, 2011.   Hoshi N, Hattori R, Hanatani K, Okuyama K, et al. (1999). Recent trends in the prevalence of Down syndrome in Japan, 1980-1997. Am. J. Med. Genet. 84: 340-345.<340::AID-AJMG6>3.0.CO;2-N   Jou HJ, Kuo YS, Hsu JJ, Shyu MK, et al. (2005). The evolving national birth prevalence of Down syndrome in Taiwan. A study on the impact of second-trimester maternal serum screening. Prenat. Diagn. 25: 665-670. PMid:16049991   Kajii T (2008). Predicted prevalence of Down syndrome live births in Japan, 1970-2006. Am. J. Med. Genet. A 146A: 1387-1388. PMid:18412276   Kuller JA and Laifer SA (1995). Contemporary approaches to prenatal diagnosis. Am. Fam. Physician 52: 2277-2286. PMid:7484721   Lai FM, Woo BH, Tan KH, Huang J, et al. (2002). Birth prevalence of Down syndrome in Singapore from 1993 to 1998. Singapore Med. J. 43: 70-76.   Marriage Statistics (2012). Turkish Statistical Institute Web Services. Available at [ do?tb_id=37&ust_id=11]. Accessed September 6, 2011.   Métneki J and Czeizel AE (2005). Increasing total prevalence rate of cases with Down syndrome in Hungary. Eur. J. Epidemiol. 20: 535 -525.   Mihci E, Akcurin G, Eren E, Kardelen F, et al. (2010). Evaluation of congenital heart diseases and thyroid abnormalities in children with Down syndrome. Anadolu Kardiyol. Derg. 10: 440-445. PMid:20929702   Olsen CL, Cross PK and Gensburg LJ (2003). Down syndrome: interaction between culture, demography, and biology in determining the prevalence of a genetic trait. Hum. Biol. 75: 503-520. PMid:14655874   OMIM (2011). Online Mendelian Inheritance in Man Web Services. Available at []. Accessed September 6, 2011.   Shin M, Besser LM, Kucik JE, Lu C, et al. (2009). Prevalence of Down syndrome among children and adolescents in 10 regions of the United States. Pediatrics 124: 1565-1571. PMid:19948627   Takeuchi A, Ehara H, Ohtani K, Maegaki Y, et al. (2008). Live birth prevalence of Down syndrome in Tottori, Japan, 1980-1999. Am. J. Med. Genet. A 146A: 1381-1386. PMid:18412274   Tran SH, Caughey AB and Norton ME (2005). Ethnic variation in the prevalence of echogenic intracardiac foci and the association with Down syndrome. Ultrasound Obstet. Gynecol. 26: 158-161. PMid:16038014   Turkey Disability Survey 2002 Booklet (2011). ISBN 975 - 19 - 3596 - 2. Turkish Statistical Institute Web Services. Available at []. Accessed September 6, 2011.   Turkey in Statistics 2011 Booklet (2011). ISBN 978-975-19-5134-2. Turkish Statistical Institute Web Services. Available at []. Accessed September 6, 2011.   Turkish Statistical Institute Website (2011). Available at []. Accessed September 6, 2011.   Unalan T and Yavuz S (2004). Chapter 8 Fertility Preferences. In: 2003 Turkey Demographic and Health Survey, 97-106. Available at []. Accessed September 6, 2011.   Weijerman ME, van Furth AM, van der Mooren MD, van Weissenbruch MM, et al. (2010). Prevalence of congenital heart defects and persistent pulmonary hypertension of the neonate with Down syndrome. Eur. J. Pediatr. 169: 1195-1199. PMid:20411274 PMCid:2926442   WHO - Genomic Resources Center - Genes and Human Disease - Chromosomal Diseases - Down Syndrome (2011). WHO Web Services. Available at []. Accessed September 6, 2011.   WHO Turkey Health Profile 2011 Report (2011). WHO Web Service. Available at []. Accessed September 6, 2011.
H. Bulut, Pehlivan, M., Alper, S., Tomatir, A. G., Onay, H., Yüksel, S. E., Özkinay, F., and Pehlivan, S., Lack of association between catalase gene polymorphism (T/C exon 9) and susceptibility to vitiligo in a Turkish population, vol. 10, pp. 4126-4132, 2011.
Alkhateeb A, Stetler GL, Old W, Talbert J, et al. (2002). Mapping of an autoimmunity susceptibility locus (AIS1) to chromosome 1p31.3-p32.2. Hum. Mol. Genet. 11: 661-667. PMid:11912181   Alkhateeb A, Fain PR, Thody A, Bennett DC, et al. (2003). Epidemiology of vitiligo and associated autoimmune diseases in Caucasian probands and their families. Pigment Cell Res. 16: 208-214. PMid:12753387   Arcos-Burgos M, Parodi E, Salgar M, Bedoya E, et al. (2002). Vitiligo: complex segregation and linkage disequilibrium analyses with respect to microsatellite loci spanning the HLA. Hum. Genet. 110: 334-342. PMid:11941482   Barona MI, Arrunategui A, Falabella R and Alzate A (1995). An epidemiologic case-control study in a population with vitiligo. J. Am. Acad. Dermatol. 33: 621-625.   Bell GI, Najarian RC, Mullenbach GT and Hallewell RA (1986). cDNA sequence coding for human kidney catalase. Nucleic Acids Res. 14: 5561-5562. PMid:3755526 PMCid:311562   Casp CB, She JX and McCormack WT (2002). Genetic association of the catalase gene (CAT) with vitiligo susceptibility. Pigment Cell Res. 15: 62-66. PMid:11837458   Casp CB, She JX and McCormack WT (2003). Genes of the LMP/TAP cluster are associated with the human autoimmune disease vitiligo. Genes Immun. 4: 492-499. PMid:14551602   Chen JJ, Huang W, Gui JP, Yang S, et al. (2005). A novel linkage to generalized vitiligo on 4q13-q21 identified in a genomewide linkage analysis of Chinese families. Am. J. Hum. Genet. 76: 1057-1065. PMid:15809929 PMCid:1196443   Das SK, Majumder PP, Chakraborty R, Majumdar TK, et al. (1985a). Studies on vitiligo. I. Epidemiological profile in Calcutta, India. Genet. Epidemiol. 2: 71-78. PMid:4054593   Das SK, Majumder PP, Majumdar TK and Haldar B (1985b). Studies on vitiligo. II. Familial aggregation and genetics. Genet. Epidemiol. 2: 255-262. PMid:3932126   Em S, Laddha NC, Chatterjee S, Gani AR, et al. (2007). Association of catalase T/C exon 9 and glutathione peroxidase codon 200 polymorphisms in relation to their activities and oxidative stress with vitiligo susceptibility in Gujarat population. Pigment Cell Res. 20: 405-407. PMid:17850515   Fain PR, Gowan K, LaBerge GS, Alkhateeb A, et al. (2003). A genomewide screen for generalized vitiligo: confirmation of AIS1 on chromosome 1p31 and evidence for additional susceptibility loci. Am. J. Hum. Genet. 72: 1560-1564. PMid:12707860 PMCid:1180316   Forsberg L, Lyrenas L, de FU and Morgenstern R (2001). A common functional C-T substitution polymorphism in the promoter region of the human catalase gene influences transcription factor binding, reporter gene transcription and is correlated to blood catalase levels. Free Radic. Biol. Med. 30: 500-505.   Gavalas NG, Akhtar S, Gawkrodger DJ, Watson PF, et al. (2006). Analysis of allelic variants in the catalase gene in patients with the skin depigmenting disorder vitiligo. Biochem. Biophys. Res. Commun. 345: 1586-1591. PMid:16729966   Góth L, Rass P and Madarasi I (2001). A novel catalase mutation detected by polymerase chain reaction-single strand conformation polymorphism, nucleotide sequencing, and western blot analyses is responsible for the type C of Hungarian acatalasemia. Electrophoresis 22: 49-51.<49::AID-ELPS49>3.0.CO;2-W   Hafez M, Sharaf L and Abd el-Nabi SM (1983). The genetics of vitiligo. Acta Derm. Venereol. 63: 249-251. PMid:6192645   Hann SK and Nordlund JJ (2000). Vitiligo. Blackwell Science, Oxford.   Howitz J, Brodthagen H, Schwartz M and Thomsen K (1977). Prevalence of vitiligo. Epidemiological survey on the Isle of Bornholm, Denmark. Arch. Dermatol. 113: 47-52. PMid:831622   Jin SY, Park HH, Li GZ, Lee HJ, et al. (2004). Association of angiotensin converting enzyme gene I/D polymorphism of vitiligo in Korean population. Pigment Cell Res. 17: 84-86. PMid:14717849   Le Poole IC, Sarangarajan R, Zhao Y, Stennett LS, et al. (2001). 'VIT1', a novel gene associated with vitiligo. Pigment Cell Res. 14: 475-484. PMid:11775060 PMCid:1747534   Lv YJ, Liao WJ, Luan Q, Wang H, et al. (2011). The polymorphism of catalase T/C codon 389 in exon 9 and vitiligo susceptibility: a meta-analysis. J. Eur. Acad. Dermatol. Venereol. 25: 955-958. PMid:21054578   Majumder PP, Das SK and Li CC (1988). A genetical model for vitiligo. Am. J. Hum. Genet. 43: 119-125. PMid:3400640 PMCid:1715367   Majumder PP, Nordlund JJ and Nath SK (1993). Pattern of familial aggregation of vitiligo. Arch. Dermatol. 129: 994-998. PMid:8352624   Maresca V, Roccella M, Roccella F, Camera E, et al. (1997). Increased sensitivity to peroxidative agents as a possible pathogenic factor of melanocyte damage in vitiligo. J. Invest. Dermatol. 109: 310-313. PMid:9284096   Mehta NR, Shah KC, Theodore C, Vyas VP, et al. (1973). Epidemiological study of vitiligo in Surat area, South Gujarat. Indian J. Med. Res. 61: 145-154.   Nath SK, Majumder PP and Nordlund JJ (1994). Genetic epidemiology of vitiligo: multilocus recessivity cross-validated. Am. J. Hum. Genet. 55: 981-990. PMid:7977362 PMCid:1918341   Nordlund JJ (1997). The epidemiology and genetics of vitiligo. Clin. Dermatol. 15: 875-878.   Park HH, Ha E, Uhm YK, Jin SY, et al. (2006). Association study between catalase gene polymorphisms and the susceptibility to vitiligo in Korean population. Exp. Dermatol. 15: 377-380. PMid:16630078   Schallreuter KU, Wood JM and Berger J (1991). Low catalase levels in the epidermis of patients with vitiligo. J. Invest. Dermatol. 97: 1081-1085. PMid:1748819   Schallreuter KU, Moore J, Wood JM, Beazley WD, et al. (1999). In vivo and in vitro evidence for hydrogen peroxide (H2O2) accumulation in the epidermis of patients with vitiligo and its successful removal by a UVB-activated pseudocatalase. J. Investig. Dermatol. Symp. Proc. 4: 91-96. PMid:10537016   Spritz RA, Gowan K, Bennett DC and Fain PR (2004). Novel vitiligo susceptibility loci on chromosomes 7 (AIS2) and 8 (AIS3), confirmation of SLEV1 on chromosome 17, and their roles in an autoimmune diathesis. Am. J. Hum. Genet. 74: 188-191. PMid:14691733 PMCid:1181907   Yang S, Wang JY, Gao M, Liu HS, et al. (2005). Association of HLA-DQA1 and DQB1 genes with vitiligo in Chinese Hans. Int. J. Dermatol. 44: 1022-1027. PMid:16409268   Zhang XJ, Liu JB, Gui JP, Li M, et al. (2004a). Characteristics of genetic epidemiology and genetic models for vitiligo. J. Am. Acad. Dermatol. 51: 383-390. PMid:15337981   Zhang XJ, Liu HS, Liang YH, Sun LD, et al. (2004b). Association of HLA class I alleles with vitiligo in Chinese Hans. J. Dermatol. Sci. 35: 165-168. PMid:15265531   Zhang XJ, Chen JJ and Liu JB (2005). The genetic concept of vitiligo. J. Dermatol. Sci. 39: 137-146. PMid:16140217